BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20160487)

  • 21. Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.
    Konradi S; Yasmin N; Haslwanter D; Weber M; Gesslbauer B; Sixt M; Strobl H
    Eur J Immunol; 2014 Feb; 44(2):553-60. PubMed ID: 24165969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
    Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
    Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
    Wang Y; Wu Z; Hu L
    Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
    Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
    Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops.
    Zhang J; Tian XJ; Zhang H; Teng Y; Li R; Bai F; Elankumaran S; Xing J
    Sci Signal; 2014 Sep; 7(345):ra91. PubMed ID: 25270257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas.
    Göppel J; Möckelmann N; Münscher A; Sauter G; Schumacher U
    Anticancer Res; 2017 Oct; 37(10):5435-5440. PubMed ID: 28982853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
    Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
    Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward decoding the principles of cancer metastasis circuits.
    Lu M; Jolly MK; Onuchic J; Ben-Jacob E
    Cancer Res; 2014 Sep; 74(17):4574-87. PubMed ID: 25183783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor initiation via loss of cell contact inhibition versus Ras mutation: do all roads lead to EMT?
    Liu Y; Dean DC
    Cell Cycle; 2010 Mar; 9(5):897-900. PubMed ID: 20160473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.
    Kothari AN; Arffa ML; Chang V; Blackwell RH; Syn WK; Zhang J; Mi Z; Kuo PC
    J Clin Med; 2016 Mar; 5(4):. PubMed ID: 27023622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
    Peinado H; Olmeda D; Cano A
    Nat Rev Cancer; 2007 Jun; 7(6):415-28. PubMed ID: 17508028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis.
    Nieszporek A; Skrzypek K; Adamek G; Majka M
    Acta Biochim Pol; 2019 Dec; 66(4):509-520. PubMed ID: 31883362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 39. Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.
    Postigo AA
    EMBO J; 2003 May; 22(10):2443-52. PubMed ID: 12743038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.